Der opnåedes samstemmende blodeksponering ved sammenligning af plasmakoncentrationer hos voksne patienter, der fik busulfan peroralt og intravenøst i doser på hhv.
Similar blood exposure was observed when comparing plasma concentrations in adult patients receiving oral and intravenous busulfan at 1 mg/ kg and 0.8 mg/ kg respectively.